Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2020 Jan 13;145(6):1664–1672.e10. doi: 10.1016/j.jaci.2019.12.908

Table 1.

Summary of clinical characteristics in DADA2 patients with PRCA or BMF

PRCA BMF
Number of cases 5 10
Median age of onset (year) 0.3 2.2
Sex (% female) 40 50
Anemia (%) 100 80
Lymphopenia (%) 0 40
Neutropenia (%) 0 90
Thrombocytopenia (%) 0 30
Low IgG (%) 20 30
Low IgM (%) 40 60
Low IgA (%) 60 50
Recurrent infection (%) 20 80
Stroke (%) 20 0
Skin vasculitis (%) 0 20
Oral ulcers / Gingivitis (%) 20 70
Hepatosplenomegaly (%) 40 90
Death (%) 20 50